Evidence map›Paper›PMID 42623301›Full record

ArticleCancer research2026

Exercise Modulates Microbial Metabolites and Induces Stromal Remodeling in Pancreatic Cancer.

Sumedha Pareek, Robin D Wright, Riccardo Ballarò, Cayla Xue, Thais F Bartelli, Vidhi Chandra, Le Li, Justina Ortiz, Truong Lam, Hetal Patel and 22 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Exercise therapy in cancer prevention and treatment.Nature reviews. Clinical oncology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Sumedha PareekThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0001-6492-3849
Robin D WrightUniversity of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0002-1317-8073
Riccardo BallaròThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0001-5505-9024
Cayla XueThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0009-0009-6561-447X
Thais F BartelliThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0002-1373-0112
Vidhi ChandraThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0003-3642-2144
Le LiThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0009-0007-5226-4875
Justina OrtizUniversity of Texas MD Anderson Cancer Center Houston United States.ORCID 0009-0004-3412-8325
Truong LamThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0001-8634-8398
Hetal PatelThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0009-0007-1669-9513
Jonghae LeeThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0002-1182-9653
Pradeep ShresthaThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0003-3418-6790
Hannah SavageThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0003-4680-4656
Olivereen Le RouxThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0003-1882-879X
Haoyue LiuThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0003-0498-2796
Tamara Vallejo-SchmidtThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0009-0003-6930-9962
Ryan De MalekiThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0009-0006-1115-0129
Vasanta PutluriBaylor College of Medicine HOUSTON, TX United States.ORCID 0000-0001-7943-2209
Nagireddy PutluriBaylor College of Medicine HOUSTON, TEXAS United States.ORCID 0000-0003-4488-7400
Joseph F PetrosinoBaylor College of Medicine Houston, TX United States.ORCID 0000-0002-4046-6898
Jared K BurksThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0002-6173-9074
Javier A GomezThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0002-6579-744X
Jlenia GuarnerioThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0001-7576-7095
Matthew H G KatzThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0000-0003-3870-6968
An Ngo-HuangThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0000-0003-4797-4147
Laura R PrakashThe University of Texas MD Anderson Cancer Center Houston, TX United States.ORCID 0000-0003-1846-2361
Nathan H ParkerMoffitt Cancer Center Tampa, FL United States.ORCID 0000-0002-8947-7942
Maria Q B PetzelThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0000-0001-7982-8828
Lin TanThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0000-0001-5156-7814
Seyda BaydoganUniversity of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0002-9455-640X
Florencia McAllisterThe University of Texas MD Anderson Cancer Center Houston United States.ORCID 0000-0002-9915-0943
Keri L SchadlerThe University of Texas MD Anderson Cancer Center Houston, Texas United States.ORCID 0000-0002-1675-0514

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
Interrogating the Spatial and Functional Relevance of Microbes in Pancreatic Cancer and MetastasisR01CA282786 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Florencia McAllister · 2024 to 2026
$2.7M
Dissecting the Source and Mechanisms of IL-17-Mediated Modulation of Pancreatic TumorigenesisR37CA237384 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MCALLISTER, FLORENCIA · 2020 to 2025
$2.6M
PancFit: Do angiogenic biomarkers correlate with improved progression free survival in pancreatic cancer?R21CA218732 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KATZ, MATTHEW H. G., NGO-HUANG, AN THUY · 2018 to 2019
$377k
NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA282786NCI NIH HHS R21 CA218732NCI NIH HHS R37 CA237384
6 · The paper itself

Abstract

Exercise induces a variety of changes in the tumor microenvironment, with beneficial effects in several tumor types. However, a better understanding of the clinical effects of exercise and mediating mechanisms is needed to maximize the utility of exercise for patients. In this study, we analyzed tumors from patients with pancreatic ductal adenocarcinoma (PDAC) in the PancFit trial and identified an exercise-induced reduction in cells expressing α-smooth muscle actin (αSMA). Interrogation of changes in tumor stromal composition with exercise in a murine PDAC model revealed a microbially influenced reduction in αSMA+ cells and Il6-expressing inflammatory cancer-associated fibroblasts (iCAF). Cholic acid, a microbial bile acid, was increased in both patients and murine models with exercise, as a potential mediator of exercise-induced reduction in iCAFs. Consistent with these findings, patients that exercised more also exhibited fewer iCAFs and lower tumor IL6 expression, supporting a stromal remodeling effect of physical activity. In summary, this study demonstrates that the antitumor effect of exercise includes stromal remodeling, which is affected by microbial metabolites. SIGNIFICANCE: Exercise-induced changes in cancer associated fibroblasts vary with microbiome composition, which may explain the heterogeneity in tumor responses to exercise and could guide future exercise trials in cancer patients.

Identifiers

PMID42623301
PMCPMC13589411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.